83 NDCs across 16 manufacturers|80 Generic,3 Brand
Montelukast Sodium is used to treat asthma and rhinitis, allergic, perennial, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 20, 1998, and the first generic was approved Aug 3, 2012. FDA's Orange Book lists 46 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $142 million on Montelukast Sodium across 12.5 million claims for 3.2 million beneficiaries.
Montelukast Sodium is available as 83 NDCs from 16 manufacturers (80 generic, 3 brand), with NADAC prices from $0.04 to $9.27 per EA — the most expensive product costs about 218× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
83
80G / 3B
Manufacturers
16
competing in market
Price Spread
$0.04 – $9.27
per EA
7d Activity
3↑55↓25 flat
avg -0.4% WoW · of 83 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Montelukast Sodium is used to treat asthma and rhinitis, allergic, perennial, per the National Library of Medicine's MED-RT classification.
When did Montelukast Sodium become available as a generic?
FDA approved the first generic Montelukast Sodium (ANDA) on Aug 3, 2012. The Orange Book currently lists 46 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Montelukast Sodium?
In 2024, Medicare Part D spent $142 million on Montelukast Sodium across 12.5 million claims for 3.2 million beneficiaries.
How many Montelukast Sodium products are on the market?
The Montelukast Sodium drug market contains 83 NDCs from 16 manufacturers — 80 generic and 3 brand products.
What is the price range for Montelukast Sodium?
NADAC reference prices for Montelukast Sodium range from $0.0425 to $9.2741 per EA — the most expensive product costs about 218× the cheapest.
Is generic Montelukast Sodium cheaper than brand?
The average generic NADAC for Montelukast Sodium is $0.1058 per EA, versus $9.2316 for brand-labeled products — brand versions average about 87× the generic price.
Which manufacturers make Montelukast Sodium?
16 manufacturers list Montelukast Sodium in NADAC. Ranked by number of NDCs, the largest are Torrent Pharmaceuticals Limited (11), Aurobindo Pharma Limited (10), Unichem Pharmaceuticals (USA) Inc. (9), Rising Pharma Holdings Inc. (8), Dr. Reddy's Laboratories Inc. (7).
How has the price of Montelukast Sodium changed recently?
Over the past 7 days, 3 Montelukast Sodium NDCs rose and 55 fell, with a market-wide average change of -0.4%.